Author Information
Marie Helleberg is a prominent researcher affiliated with the Department of Infectious Diseases at Copenhagen University Hospital (Rigshospitalet) in Copenhagen, Denmark. Additionally, she is associated with the Faculty of Health Sciences at the University of Copenhagen. Her expertise primarily lies in infectious diseases, with a significant focus on COVID-19 and related complications.Research Contributions
Marie Helleberg has made substantial contributions to the understanding and management of infectious diseases, particularly focusing on COVID-19. In 2022 alone, she co-authored several noteworthy papers, including studies on the severity and survival of SARS-CoV-2 infections among patients with hematological disorders and the efficacy of hyperimmune immunoglobulin for hospitalized COVID-19 patients. Her research extends to evaluating treatment options such as dexamethasone and remdesivir, as well as examining the risks associated with the COVID-19 omicron variant in patients with chronic lymphocytic leukemia (CLL). Additionally, her work includes insights into the diagnostic evaluation of hospitalized COVID-19 patients and sustained recovery outcomes. Her diverse research interests also cover topics like human subcutaneous dirofilariasis and postpartum disseminated HSV-1 infection.Aliases
Throughout her academic career, Marie Helleberg has been referenced under several aliases, including M Helleberg and M. Helleberg. However, her full name, Marie Helleberg, is the most appropriate and comprehensive representation of her identity in the academic community.Publication and Citation Metrics
| Metric |
Value |
| Number of Papers |
160 |
| Citation Count |
3160 |
| h-index |
29 |
